Literature DB >> 22057395

Co-morbidity of Kawasaki disease.

Fang-Liang Huang1, Te-Kau Chang, Sheng-Ling Jan, Chi-Ren Tsai, Li-Chung Wang, Mei-Chin Lai, Po-Yen Chen.   

Abstract

Despite more than four decades of investigation, the etiology of Kawasaki disease remains obscure, and none of the proposed etiologic theories for the disease have achieved independent confirmation. Clinical and epidemiologic features support an infectious cause, but the etiology remains unclear. The authors present a case of Kawasaki disease associated with Epstein-Barr virus and Mycoplasma pneumoniae infection in a 3.5-y-old boy. He received two doses of intravenous immunoglobulin due to prolonged course of Kawasaki disease but later had complicated autoimmune haemolytic anaemia. His prolonged fever subsided after azithromycin administration. Epstein-Barr virus infection was confirmed by molecular microbiological pathology of cervical lymph node and serological tests. The serological tests for Mycoplasma pneumoniae also revealed a positive result. Thus, it is concluded that Mycoplasma pneumoniae and Epstein-Barr virus infections may occur simultaneously in a child with Kawasaki disease. In addition, autoimmune hemolytic anaemia may be noted in Kawasaki disease patients after high-dose IVIG administration. To the authors' knowledge, this is the first report of Kawasaki disease with Epstein-Barr virus and Mycoplasma pneumoniae in the English-language literature.

Entities:  

Mesh:

Year:  2011        PMID: 22057395     DOI: 10.1007/s12098-011-0589-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  10 in total

Review 1.  Superantigens, conventional antigens and the etiology of Kawasaki syndrome.

Authors:  H C Meissner; D Y Leung
Journal:  Pediatr Infect Dis J       Date:  2000-02       Impact factor: 2.129

2.  Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.

Authors:  M Nakagawa; N Watanabe; M Okuno; M Kondo; H Okagawa; T Taga
Journal:  Am J Hematol       Date:  2000-03       Impact factor: 10.047

3.  Mycoplasma pneumoniae infection associated with Kawasaki disease.

Authors:  J N Wang; S M Wang; C C Liu; J M Wu
Journal:  Acta Paediatr       Date:  2001-05       Impact factor: 2.299

4.  Two cases of lymphadenopathy with liver dysfunction due to Mycoplasma pneumoniae infection with mycoplasmal bacteraemia without pneumonia.

Authors:  M Narita; S Yamada; T Nakayama; H Sawada; M Nakajima; S Sageshima
Journal:  J Infect       Date:  2001-02       Impact factor: 6.072

Review 5.  Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review.

Authors:  Fahmi Yousef Khan; Mohamed A yassin
Journal:  Braz J Infect Dis       Date:  2009-02       Impact factor: 1.949

6.  Long-term observation in patients with Kawasaki syndrome and their relation to Epstein-Barr virus infection.

Authors:  M Okano; N Hase; Y Sakiyama; S Matsumoto
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

7.  Mycoplasma infection and Kawasaki disease.

Authors:  C Leen; S Ling
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

8.  Kawasaki disease and Epstein-Barr virus.

Authors:  M Iwanaga; K Takada; T Osato; Y Saeki; S Noro; N Sakurada
Journal:  Lancet       Date:  1981-04-25       Impact factor: 79.321

9.  Mycoplasma pneumoniae infection associated with hemolytic anemia--report of one case.

Authors:  Jinn-Li Wang; Man-Yau Ho; Ein-Yiao Shen
Journal:  Acta Paediatr Taiwan       Date:  2004 Sep-Oct

Review 10.  Pathogenesis and management of Kawasaki disease.

Authors:  Anne H Rowley; Stanford T Shulman
Journal:  Expert Rev Anti Infect Ther       Date:  2010-02       Impact factor: 5.091

  10 in total
  2 in total

1.  Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study.

Authors:  Etsuro Nanishi; Hisanori Nishio; Hidetoshi Takada; Kenichiro Yamamura; Mitsuharu Fukazawa; Kenji Furuno; Yumi Mizuno; Kenjiro Saigo; Ryo Kadoya; Noriko Ohbuchi; Yasuhiro Onoe; Hironori Yamashita; Hideki Nakayama; Takuya Hara; Takuro Ohno; Yasuhiko Takahashi; Ken Hatae; Tatsuo Harada; Takayuki Shimose; Junji Kishimoto; Shouichi Ohga; Toshiro Hara
Journal:  J Am Heart Assoc       Date:  2017-07-06       Impact factor: 5.501

2.  Comorbidity of Kawasaki disease and group a streptococcal pleural effusion in a healthy child: a case report.

Authors:  Ahmed H Alhammadi; Mohamed A Hendaus
Journal:  Int J Gen Med       Date:  2013-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.